Mulé, J J <br/><br/>
The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  May 1986 
 - 3899-909 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Surface--analysis<br/>Cell Differentiation<br/>Cytotoxicity, Immunologic--radiation effects<br/>Female<br/>Immunity, Cellular--radiation effects<br/>Immunization, Passive<br/>Immunotherapy<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Natural--immunology<br/>Lung--cytology<br/>Lung Neoplasms--secondary<br/>Lymphokines--therapeutic use<br/>Mice<br/>Mice, Inbred C57BL<br/>Recombinant Proteins--therapeutic use<br/>Sarcoma, Experimental--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Thy-1 Antigens<br/>Thymectomy